AI analytics for smarter drug decisions
Make decisions efficiently — get answers in days, not months
The challenge
Make biopharma decisions 8x faster
Portfolio gaps
Patent cliffs, competition, and shifting regulations make it difficult to build a comprehensive portfolio.
Evolving strategies
As assets and drug landscapes change, ongoing drug program analysis lags due to lack of time and expertise.
Global asset coverage
Fast, deep, and ongoing analysis of data and assets from China, Japan, Korea, and dozens of other countries.
Complex science
Each program needs a comprehensive evaluation of interdisciplinary science and risks.
What can AI do?
Transform every drug program decision
Avoid the months of manually sourcing and onboarding expertise. Analysis with artificial intelligence gives you a clear path to choose the highest potential drugs, create risk mitigation plans, and more.
- Understand and identify programs in an indication
- Assess key development risks, benchmark against the Standard of Care, and perform competitive analysis.
- Identify strengths and risks of a specific program and develop a detailed plan to move forward with internal teams.
Area |
Traditional method |
AI-enabled outcomes |
|
Indication selection |
Manual synthesis of dozens of sources |
Instant mapping of opportunity landscape |
|
Portfolio review |
Excel spreadsheets and gut instinct |
Probabilistic scoring by success metrics |
|
Diligence |
Months of labor-intensive reviews |
Real-time risk analysis |
Results
Cut through noise & expedite decisions with AI analysis
Powered by artificial intelligence and large language models, AI analyst platforms can help you quickly cull through hundreds of potential drug programs and perform deep, accurate analysis on specific high-potential candidates.
“Understanding specific risks, rather than abstract probabilities, provides the clearest path to good decisions.”
Jay Andersen, Lead at Oaken Table Consulting and University of Minnesota PhD statistician
Who is it for?
Gain a strategic edge
Vibe Bio empowers Chief Strategy Officers and Business Development teams to make strategic decisions with confidence.
Never miss an asset
Uncover hidden gems
Build cross-functional trust through evidence
Validate asset fit and risk earlier
GenAI is a competitive necessity
Learn how top biopharma teams are applying AI analytics in business development or portfolio prioritization projects.